Richard I. Eisenstadt
VP, Finance & C.F.O., Ocera Therapeutics, Inc.
Companies
- Altimmune, Inc.Chief financial officer Jan 4, 2022 to Feb 1, 20241
- AYTU BIOPHARMA, INCChief financial officer Apr 5, 2021 to Apr 5, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Altimmune, Inc. ALT45,012 shares3$104.5K at $2.32Jan 31, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 31, 2024Granted 4,621 shares at $2.69 of Altimmune, Inc.3
- Jan 30, 2024Shares withheld for tax 2,175 shares at $9.80 of Altimmune, Inc.3
- Jan 30, 2024Exercised options 9,275 shares of Altimmune, Inc.3
- Dec 29, 2023Shares withheld for tax 3,044 shares at $11.25 of Altimmune, Inc.4
- Dec 29, 2023Exercised options 12,500 shares of Altimmune, Inc.4
- Jul 31, 2023Granted 1,825 shares at $2.81 of Altimmune, Inc.5
- Mar 24, 2023Bought 10,000 shares at $4.31 of Altimmune, Inc.6
- Jan 31, 2023Granted 1,172 shares at $10.21 of Altimmune, Inc.7
- Dec 31, 2022Shares withheld for tax 3,028 shares at $16.45 of Altimmune, Inc.8
- Dec 31, 2022Exercised options 12,500 shares of Altimmune, Inc.8
- Jul 31, 2022Granted 1,366 shares at $6.86 of Altimmune, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 2, 2024
- 5SEC EDGARForm 4 filed Aug 2, 2023
- 6SEC EDGARForm 4 filed Mar 24, 2023
- 7SEC EDGARForm 4 filed Feb 2, 2023
- 8SEC EDGARForm 4 filed Jan 3, 2023
- 9SEC EDGARForm 4 filed Aug 3, 2022